Systematic review of overactive bladder therapy in females
Author:
Open Access
- 15 April 2013
- journal article
- review article
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 5 (5) , 139
Abstract
Although the prevalence of overactive bladder (OAB) is similarin both male and female populations, females have a greater tendencyto seek medical advice regarding their symptoms. A reviewof the evidence of therapy among women shows that a variety ofmodalities has been shown to be effective for symptom improvementin women with OAB. Bladder retraining/re-education shouldbe considered for all women with OAB. With respect to first-linepharmacotherapy with antimuscarinic agents, the development ofextended release preparations, bladder selective M3 antagonistsand alternative routes of delivery, have improved compliance andpersistence. Other pharmacotherapeutic options with potential forproviding benefit include antidepressants, vasopressin analogues,alpha-adrenoceptor antagonists and beta-adrenoceptor agonists.There are also a number of newer agents currently being investigated,including calcium channel blocking agents, potassium channelopening drugs, beta agonists and neurokinin receptor antagonists.Intravesical injections of botulinum toxin may be an alternative,while surgery can be considered for truly intractable cases.Keywords
This publication has 17 references indexed in Scilit:
- Inpatient bladder retraining: is it beneficial on its own?International Urogynecology Journal, 2010
- Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy TrialJournal of Urology, 2009
- Is There a Synergistic Effect of Topical Oestrogens When Administered with Antimuscarinics in the Treatment of Symptomatic Detrusor Overactivity?European Urology, 2009
- Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndromeNeurourology and Urodynamics, 2008
- Desmopressin, as a “designer‐drug,” in the treatment of overactive bladder syndromeNeurourology and Urodynamics, 2008
- Refractory Idiopathic Urge Urinary Incontinence and Botulinum A InjectionJournal of Urology, 2008
- Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature ReviewEuropean Urology, 2008
- Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Outcomes of a Prospective, Worldwide Clinical StudyJournal of Urology, 2007
- Posterior tibial nerve stimulation in the treatment of urge incontinenceNeurourology and Urodynamics, 2002
- Nocturnal enuresis: An approach to treatment based on pathogenesisThe Journal of Pediatrics, 1989